Furthermore, studies have demonstrated that the DUSP6 inhibitor (E/Z)-BCI hydrochloride can modulate oxidative stress and exert anti-inflammatory effects in RA by activating the Nrf2 antioxidant signaling axis and suppressing the NF-κB pathway [40]. Here, DUSP6 is linked to rheumatoid arthritis.